The epidemic of methicillin-resistant Staphylococcus aureus colonization and infection in children: Implications for community and hospital practice

Journal of Pediatric Infectious Diseases

Volumn 1, Issue 1, 2006, Pages 7-15

  Purcella, Kevin ^a   Fergieb, Jaime ^b  

^a DRISCOLL CHILDREN S HOSPITAL   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

Author keywords

Children; Methicillin resistant; Staphylococcus aureus

Indexed keywords

EID: 85013599508     PISSN: 13057707     EISSN: 13057693     Source Type: Journal    
DOI: None     Document Type: Article

References (86)

1. M.H. Rathore and M.W. Kline, Community-acquired methicillin-resistant Staphylococcus aureus infections in children, Pediatr Infect Dis J 8 (1989), 645-647.
2. F. Moreno, C. Crisp, J.H. Jorgensen and J.E. Patterson, Methicillin-resistant Staphylococcus aureus as a community organism, Clin Infect Dis 21 (1995), 1308-1312.
3. M.C. Layton, W.J. Hierholzer and J.E. Patterson, The evolving epidemiology of methicillin-resistant Staphylococcus aureus at a university hospital, Infect Control Hosp Epidemiol 16 (1995), 12-17.
4. B.C. Herold, L.C. Immergluck, M.C. Maranan et al., Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk, JAMA 279 (1998), 593-598.
5. Anonymous, Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillinresistant Staphylococcal aureus-Minnesota and North Dakota, 1997-1999, MMWR 48 (1999), 707-710.
6. E.J. Gorak, S.M. Yamada and J.D. Brown, Communityacquired methicillin-resistant Staphylococcus aureus in hospitalized adults and children without known risk factors, Clin Infect Dis 29 (1999), 797-800.
7. A.L. Frank, J.F. Marcinak, P.D. Mangat and P.C. Schreckenberger, Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children, Pediatr Infect Dis J 18 (1999), 993-1000.
8. A.L. Frank, J.F. Marcinak, P.D. Mangat and P.C. Schreckenberger, Increase in community-acquired methicillin-resistant Staphylococcus aureus in children, Clin Infect Dis 29 (1999), 935-936.
9. F.M. Hussain, S. Boyle-Vavra, C.D. Bethel and R.S. Daum, Current trends in community-acquired methicillin-resistant Staphylococcus aureus at a tertiary care pediatric facility, Pediatr Infect Dis J 19 (2000), 1163-1166.
10. J.E. Fergie and K. Purcell, Community-acquired methicillinresistant Staphylococcus aureus infections in South Texas children, Pediatr Infect Dis J 20 (2001), 860-863.
11. A.V. Groom, D.H. Wolsey, T.S. Naimi et al., Communityacquired methicillin-resistant Staphylococcus aureus infections in a rural American Indian community, JAMA286 (2001), 1201-1205.
12. K. Purcell and J. Fergie, Exponential increase in communityacquired methicillin-resistant Staphylococcus aureus in South Texas children, Pediatr Infect Dis J 21 (2002), 988-989.
13. C.A. Sattler, E.O. Mason and S.L. Kaplan, Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infections in children, Pediatr Infect Dis J 21 (2002), 910-917.
14. T.S. Naimi, K.H. LeDell, K. Como-Sabetti et al., Comparison of community-and health care-associated methicillin-resistant Staphylococcus aureus infection, JAMA 290 (2003), 2976-2984.
15. S.C. Buckingham, L.K. McDougal, L.D. Cathey et al., Emergence of community-associated methicillin-resistant Staphylococcus aureus at a Memphis, Tennessee Children’s Hospital, Pediatr Infect Dis J 23 (2004), 619-624.
16. C. Alfaro, J. Fergie and K. Purcell, Emergence of communityacquired methicillin-resistant Staphylococcus aureus in complicated parapneumonic effusions, Pediatr Infect Dis J 24 (2005), 274-276.
17. S.L. Kaplan, K.G. Hulten, B.E. Gonzalez et al., Three-year surveillance of community-acquired Staphylococcus aureus infections in children, Clin Infect Dis 40 (2005), 1785-1791.
18. K. Purcell and J. Fergie, Epidemic of community-acquired methicillin-resistant Staphylococcus aureus infections: a 14-year study at Driscoll Children’s Hospital, Arch Pediatr Adolesc Med 159 (2005), 980-985.
19. F. Vandenesch, T. Naimi, M.C. Enright et al., Communityacquired methicillin-resistant Staphylococcus aureus carrying Panton-Valentine leukocidin genes: worldwide emergence, Emerg Infect Dis 9 (2003), 978-984.
20. F.F. Barrett, R.F. McGehee Jr. and M. Finland, Methicillinresistant Staphylococcus aureus at Boston City Hospital. Bacteriologic and epidemiologic observations, N Engl J Med 279 (1968), 441-448.
21. F.D. Lowy, Staphylococcus aureus infections, N Engl J Med 339 (1998), 520-532.
22. Anonymous, From the Centers for Disease Control and Prevention. Community-acquired methicillin-resistant Staphylococcal aureus infections-Michigan, MMWR 30 (1981), 185-187.
23. P.M. Adcock, P. Pastor, F. Medley, J.E. Patterson and T.V. Murphy, Methicillin-resistant Staphylococcus aureus in two child care centers, J Infect Dis 178 (1998), 577-580.
24. J.M. Lindenmayer, S. Schoenfeld, R. O’Grady and J.K. Carney, Methicillin-resistant Staphylococcus aureus in a high school wrestling team and the surrounding community, Arch Intern Med 158 (1998), 895-899.
25. R. Shahin, I.L. Johnson, F. Jamieson, A. McGeer, J. Tolkin and E.L. Ford-Jones, Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease, Arch Pediatr Adolesc Med 153 (1999), 864-868.
26. A.H. Suggs, M.C. Maranan, S. Boyle-Vavra and R.S. Daum, Methicillin-resistant and borderline methicillinresistant asymptomatic Staphylococcus aureus colonization in children without identifiable risk factors, Pediatr Infect Dis J 18 (1999), 410-414.
27. F.M. Hussain, S. Boyle-Vavra and R.S. Daum, Communityacquired methicillin-resistant Staphylococcus aureus colonization in healthy children attending an outpatient pediatric clinic, Pediatr Infect Dis J 20 (2001), 763-767.
28. M.M. Nakamura, K.L. Rohling, M. Shashaty et al., Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in the community pediatric population, Pediatr Infect Dis J 21 (2002), 917-921.
29. L. Cheng Immergluck, S. Kanungo, A. Schwartz, A. McIntyre, P.C. Schreckenberger and P.S. Diaz, Prevalence of Streptococcus pneumoniae and Staphylococcus aureus nasopharyngeal colonization in healthy children in the United States, Epidemiol Infect 132 (2004), 159-166.
30. C.B. Creech, D.S. Kernodle, A. Alsentzer et al., Increasing rates of nasal carriage of methicillin-resistant Staphylococcus aureus in healthy children, Pediatr Infect Dis J 24 (2005), 617-621.
31. E.E. Foglia, E. Dubberke, H. Reno et al., Nasal carriage of Staphylococcus aureus and MRSA: point prevalence study in children, in: Final program and abstracts book for the Society for Healthcare Epidemiology of America 2005 Annual Meeting, Los Angeles, CA, April 9 to 12, 2005. Alexandria, VA: Society for Healthcare Epidemiology of America, 2005.
32. C. Alfaro, M. Mascher-Denen, J. Fergie and K. Purcell, Prevalence of methicillin-resistant Staphylococcus aureus nasal carriage in patients admitted to Driscoll Children’s Hospital, Pediatr Infect Dis J, in press.
33. K. Purcell and J. Fergie, Increase in hospitalizations for cellulitis and abscess concurrent with the epidemic of communityacquired methicillin-resistant Staphylococcus aureus infections in children, in: Final program and abstracts book for the 2005 Annual Meeting of the Pediatric Academic Societies, Washington, D.C., May 14-17,2005. The Woodlands, TX:Pediatric Academic Societies, 2005
34. K. Purcell, J. Fergie and M.D. Peterson, Economic impact of the community-acquired methicillin-resistant Staphylococcus aureus epidemic on the Driscoll Children’s Health Plan, Pediatr Infect Dis J 25 (2006), 178-180.
35. J.S. Garner, W.R. Jarvis, T.G. Emori et al., CDC definitions for nosocomial infections, 1988, Am J Infect Control 16 (1988), 128-140.
36. C.D. Salgado, B.M. Farr and D.P. Calfee, Communityacquired methicillin-resistant Staphylococcus aureus: a metaanalysis of prevalence and risk factors, Clin Infect Dis 36 (2003), 131-139.
37. R.S. Daum, T. Ito, K. Hiramatsu et al., A novel methicillinresistance cassette in community-acquired methicillinresistant Staphylococcus aureus isolates of diverse genetic backgrounds, J Infect Dis 186 (2002), 1344-1347.
38. T. Ito, Y. Katayama, K. Asada, N. Mori, K. Tsutsumimoto, C. Tiensasitorn and K. Hiramatsu, Structural comparison of three types of staphylococcal cassette chromosome mec integrated in the chromosome in methicillin-resistant Staphylococcus aureus, Antimicrob Agents Chemother 45 (2001), 1323-1336.
39. X.X. Ma, T. Ito, C. Tiensasitorn et al., Novel type of staphylococcal cassette chromosome mec identified in communityacquired methicillin-resistant Staphylococcus aureus strains, Antimicrob Agents Chemother 46 (2002), 1147-1152.
40. T. Ito, X.X. Ma, F. Takeuchi et al., Novel type V staphylococcal cassette chromosome mec driven by a novel cassette chromosome recombinase, ccrC, Antimicrob Agents Chemother 48 (2004), 2637-2651.
41. L.K. McDougal, C.D. Steward, G.E. Killgore, J.M. Chaitram, S.K. McAllister and F.C. Tenover, Pulsed-field gel electrophoresis typing of oxacillin-resistant Staphylococcus aureus isolates from the United States: establishing a national database, J Clin Microbiol 41 (2003), 5113-5120.
42. Y. Gillet, B. Issartel, P. Vanhems et al., Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients, Lancet 359 (2002), 753-759.
43. O. Yamasaki, J. Kaneko, S. Morizane et al., The association between Staphylococcus aureus strains carrying Panton-Valentine leukocidin genes and the development of deepseated follicular infection, Clin Infect Dis 40 (2005), 381-385.
44. T. Baba, F. Takeuchi, M. Kuroda et al., Genome and virulence determinants of high virulence community-acquired MRSA, Lancet 359 (2002), 1819-1827.
45. B.E. Gonzalez, K.G. Hulten, M.K. Dishop et al., Pulmonary manifestations in children with invasive community-acquired Staphylococcus aureus infection, Clin Infect Dis 41 (2005), 583-590.
46. B.E. Gonzalez, G. Martinez-Aguilar, K.G. Hulten et al., Severe Staphylococcal sepsis in adolescents in the era of communityacquired methicillin-resistant Staphylococcus aureus, Pediatrics 115 (2005), 642-648.
47. J. Kluytmans, A. van Belkum and H. Verbrugh, Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks, Clin Microbiol Rev 10 (1997), 505-520.
48. S.S. Huang and R. Platt, Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization, Clin Infect Dis 36 (2003), 281-285.
49. C. von Eiff, K. Becker, K. Machka, H. Stammer and G. Peters, Nasal carriage as a source of Staphylococcus aureus bacteremia. Study Group, N Engl J Med 344 (2001), 11-16.
50. H.F. Wertheim, M.C. Vos, A. Ott et al., Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers, Lancet 364 (2004), 703-705.
51. K.A. Davis, J.J. Stewart, H.K. Crouch et al., Methicillinresistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection, Clin Infect Dis 39 (2004), 776-782.
52. M.W. Ellis, D.R. Hospenthal, D.P. Dooley et al., Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers, Clin Infect Dis 39 (2004), 971-979.
53. E.M. Begier, K. Frenette, N.L. Barrett et al., Connecticut Bioterrorism Field Epidemiology Response Team. A highmorbidity outbreak of methicillin-resistant Staphylococcus aureus among players on a college football team, facilitated by cosmetic body shaving and turf burns, Clin Infect Dis 39 (2004), 1446-1453.
54. Anonymous, Centers for Disease Control and Prevention Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003, MMWR 52 (2003), 793-795.
55. E.S. Pan, B.A. Diep, E.D. Charlebois, C. Auerswald, H.A. Carleton, G.F. Sensabaugh and F. Perdreau-Remington, Population dynamics of nasal strains of methicillin-resistant Staphylococcus aureus and their relation to community-associated disease activity, J Infect Dis 192 (2005), 811-818.
56. E.D. Charlebois, D.R. Bangsberg, N.J. Moss et al., Populationbased community prevalence of methicillin-resistant Staphylococcus aureus in the urban poor of San Francisco, Clin Infect Dis 34 (2002), 425-433.
57. Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus infections in correctional facilities-Georgia, California, and Texas, 2001-2003, MMWR Morb Mortal Wkly Rep 52 (2003), 992-996.
58. F. Fleisch, R. Zbinden, C.Vanoli and C. Ruef, Epidemic spread of a single clone of methicillin-resistant Staphylococcus aureus among injection drug users in Zurich, Switzerland, Clin Infect Dis 32 (2001), 581-586.
59. W.C. Mathews, J.C. Caperna, R.E. Barber, F.J. Torriani, L.G. Miller, S. May and J.A. McCutchan, Incidence of and risk factors for clinically significant methicillin-resistant Staphylococcus aureus infection in a cohort of HIV-infected adults, J Acquir Immune Defic Syndr 40 (2005), 155-160.
60. P.V. Adem, C.P. Montgomery, A.N. Husain et al., Staphylococcus aureus sepsis and Waterhouse-Friderichsen syndrome in children, N Engl J Med 353 (2005), 1245-1251.
61. L.G. Miller, F. Perdreau-Remington, G. Rieg et al., Necrotizing fasciitis caused by community-acquired methicillinresistant Staphylococcus aureus in Los Angeles, N Engl J Med 352 (2005), 1445-1453.
62. A.M. Mishaan, E.O. Mason Jr, G. Martinez-Aguilar et al., Emergence of a predominant clone of community-acquired Staphylococcus aureus among children in Houston, Texas. Pediatr Infect Dis J 24 (2005), 201-206.
63. G. Martinez-Aguilar, W.A. Hammerman, E.O. Mason and S.L. Kaplan, Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin methicillinsusceptible Staphylococcus aureus in children, Pediatr Infect Dis J 22 (2003), 593-598.
64. A.L. Frank, J.F. Marcinak, P.D. Mangat et al., Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children, Pediatr Infect Dis J 21 (2002), 530-534.
65. R. Leclercq, Mechanisms of resistance to macrolides and lincosamides:nature of the resistance elements and their clinical implications, Clin Infect Dis 34 (2002), 482-492.
66. J.S. Lewis 2nd and J.H. Jorgensen, Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned? Clin Infect Dis 40 (2005), 280-285.
67. National Committee for Clinical Laboratory Standards. Supplement M100-S14.Wayne, PA: National Committee for Clinical Laboratory Standards, 2004.
68. K.R. Fiebelkorn, S.A. Crawford, M.L. McElmeel and J.H. Jorgensen, Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci, J Clin Microbiol 41 (2003), 4740-4744.
69. W.E. Shams, M. McCormick, R.P. Rapp and M.E. Evans, The use of trimethoprim-sulfamethoxazole for serious MRSA infections, Infect Med 22 (2005), 507-510.
70. N. Markowitz, E.L. Quinn and L.D. Saravolatz, Trimethoprimsulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection, Ann Intern Med 117 (1992), 390-398.
71. V. Yeldandi, R. Strodtman and J.R. Lentino, In-vitro and invivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus, J Antimicrob Chemother 22 (1988), 873-880.
72. M.C. Lee, A.M. Rios, M.F. Aten et al., Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus, Pediatr Infect Dis J 23 (2004), 123-127.
73. C.J. Baker and R.W. Frenck, Change in management of skin/soft tissue infections needed, AAP News 25 (2004), 105.
74. G.K. Siberry, T. Tekle, K. Carroll and J. Dick, Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro, Clin Infect Dis 37 (2003), 1257-1260.
75. D. Drinkovic, E.R. Fuller, K.P. Shore et al., Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance, J Antimicrob Chemother 48 (2001), 315-316.
76. C.A. Muto, J.A. Jernigan, B.E. Ostrowsky et al., SHEA guideline for preventing nosocomial transmission of multidrugresistant strains of Staphylococcus aureus and Enterococcus, Infect Control Hosp Epidemiol 24 (2003), 362-386.
77. K.B. Laupland and J.M. Conly, Treatment of Staphylococcus aureus colonization and prophylaxis for infection with topical intranasal mupirocin: an evidence-based review, Clin Infect Dis 37 (2003), 933-938.
78. C. Cavdar, T. Atay, M. Zeybel et al., Emergence of resistance in staphylococci after long-term mupirocin application in patients on continuous ambulatory peritoneal dialysis, Adv Perit Dial 20 (2004), 67-70.
79. J.E. Vasquez, E.S.Walker, B.W. Franzus, B.K. Overbay, D.R. Reagan and F.A. Sarubbi, The epidemiology of mupirocin resistance among methicillin-resistant Staphylococcus aureus at a Veterans’ Affairs hospital, Infect Control Hosp Epidemiol 21 (2000), 459-464.
80. S.L. Kaplan, Treatment of community-associated methicillinresistant Staphylococcus aureus infections, Pediatr Infect Dis J 24 (2005), 457-458.
81. Centers for Disease Control and Prevention (CDC). Methicillin-resistant Staphylococcus aureus infections among competitive sports participants-Colorado, Indiana, Pennsylvania, and Los Angeles County, 2000-2003, MMWR Morb Mortal Wkly Rep 52 (2003), 793-795.
82. J.S. Garner, Guideline for isolation precautions in hospitals. The Hospital Infection Control Practices Advisory Committee, Infect Control Hosp Epidemiol 17 (1996), 53-80.
83. M.E. Mulligan, K.A. Murray-Leisure, B.S. Ribner et al., Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management, Am J Med 94 (1993), 313-328.
84. J.A. Cepeda, T. Whitehouse, B. Cooper et al., Isolation of patients in single rooms or cohorts to reduce spread of MRSA in intensive-care units: prospective two-centre study, Lancet 365 (2005), 295-304.
85. M.D. Kalmeijer, H. Coertjens, P.M. van Nieuwland-Bollen et al., Surgical site infections in orthopedic surgery: the effect of mupirocin nasal ointment in a double-blind, randomized, placebo-controlled study, Clin Infect Dis 35 (2002), 353-358.
86. T.M. Perl, J.J. Cullen, R.P. Wenzel et al., Mupirocin and the Risk of Staphylococcus aureus Study Team. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections, N Engl J Med 346 (2002), 1871-1877.